Delivery Order SPE2DR25D1021-SPE2DR26FNL4B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a $11,940.80 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,096.22 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $5,606.25 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL quantities, with performance completion targeted for September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,846.86 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml dosage) on October 27, 2025, with completion expected by October 28, 2025. This non-competitive, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a $1,801.80 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL units, with completion scheduled for September 4, 2025. The contract utilizes firm fixed pricing under a non-competitive, non-set-aside delivery order structure. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $8,408.40 with a completion date of September 30, 2025. This non-competitive delivery order represents a firm fixed price transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply agreement running through...
- The Defense Logistics Agency awarded a delivery order valued at $8,300.56 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL formulation). This competitively awarded, firm fixed-price delivery order is set to be completed by September 24, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under a larger Indefinite Delivery Contract vehicle. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,592.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $29,137.90 delivery order on August 28, 2025, for the supply of Trulicity 3 mg/0.5 mL pens. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNL4BDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,488.88 on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This firm fixed-price contract, with a completion date of October 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery order was awarded non-competitively as a competitively awarded contract and is being performed at the contractor's Conshohocken, Pennsylvania location. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, particularly for military and veteran healthcare systems. The Trulicity order represents one of numerous pharmaceutical deliveries the company provides through its comprehensive DLA contract vehicle, which supports the Defense Health Agency and other federal healthcare customers globally with specialty medications, brand-name and generic drugs, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 10/27/25 |